Clinical Trials Logo

Filter by:
NCT ID: NCT00903279 Withdrawn - Clinical trials for Methicillin-resistant Staphylococcus Aureus

Treatment of Patients Colonized With Methicillin-Resistant Staphylococcus Aureus Prior to Bone and Joint Surgery

TOPS-MRSA
Start date: August 2009
Phase: Phase 2
Study type: Interventional

The investigators anticipate that utilization of retapamulin preoperatively will eliminate MRSA colonization among patients who are colonized in their nares.

NCT ID: NCT00901823 Withdrawn - Clinical trials for Hypertriglyceridemia

Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline

Start date: March 2011
Phase: Phase 1
Study type: Interventional

This is a single-center, randomized, open-label, single- and multiple-dose, five-treatment, two-period, four-way parallel study comparing the pharmacokinetics (PK) of Diazoxide Choline Controlled-Release Tablet (DCCR) administered orally under fed and fasting conditions at two dose levels.

NCT ID: NCT00900692 Withdrawn - Clinical trials for Pronation Contracture

Dynamic Splinting for Excessive Pronation Following CVA

SupPro Botox
Start date: May 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to examine range of motion and lasting effects of Botox injections along with the use of the Supination Dynasplint.

NCT ID: NCT00900510 Withdrawn - Abscess Clinical Trials

Antibiotic Therapy After Incision and Drainage for Abscess

Start date: May 2009
Phase: N/A
Study type: Interventional

Background: Skin abscesses are a growing problem in the general pediatric population around the world. While the standard treatment for an abscess/boil is incision and drainage, many physicians also prescribe antibiotics, despite the lack of evidence that antibiotics are necessary to help the wound heal. The purpose of this research study is to determine whether antibiotics are necessary after incision and drainage of a skin abscess in children. This is an important question because medical evidence has shown that using antibiotics when they are not needed has contributed to the increase of bacterial antibiotic resistance. In fact, several of the antibiotics that successfully killed Staph bacteria several years ago are now no longer effective because of antibiotic resistance. Now resistant forms of Staph bacteria, called "Community-Acquired Methicillin-Resistant Staph Aureus" (CA-MRSA), account for 50-85% of all pediatric skin abscesses. If antibiotics are not necessary then withholding them when appropriate may help slow the progression of antibiotic-resistant Staph infections. Objective(s) and Hypothesis(es): The investigators believe that antibiotics are no better than placebo at achieving a cure after drainage of an abscess in a child. The objective of this study is to answer the question: Do antibiotics after abscess drainage result in a better chance of cure than placebo? Potential Impact: If abscess drainage alone is shown to be as effective as drainage followed by antibiotics, then the routine use of antibiotics for this problem could be avoided. This would help limit the increasing antibiotic resistance of bacteria (especially CA-MRSA) in communities around the world. A well-designed study may provide the evidence to change the way children are treated for abscesses in a future where antibiotic resistant bacteria will be even more of a public health challenge.

NCT ID: NCT00900445 Withdrawn - Clinical trials for Acute Lymphoblastic Leukemia

Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia

Start date: March 24, 2008
Phase:
Study type: Observational

This clinical trial is studying body mass index in younger patients receiving prednisone/prednisolone, vincristine, daunorubicin, and pegaspargase for high-risk acute lymphoblastic leukemia. Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about the affect of body mass index on the way anticancer drugs work in the body. It may also help doctors predict how patients will respond to treatment

NCT ID: NCT00899808 Withdrawn - Clinical trials for Unspecified Adult Solid Tumor, Protocol Specific

Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer

Start date: May 2006
Phase: N/A
Study type: Observational

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular markers and genetic markers in patients undergoing radiation therapy for cancer.

NCT ID: NCT00899704 Withdrawn - Clinical trials for Head and Neck Cancer

Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer

Start date: March 2008
Phase:
Study type: Observational

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at tissue samples in predicting oral cancer in patients who have undergone neck dissection for oral cancer.

NCT ID: NCT00899145 Withdrawn - Breast Carcinoma Clinical Trials

Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

Start date: May 2008
Phase: N/A
Study type: Observational

This research study is looking at breast cancer risk in women who are BRCA1/BRCA2 mutation carriers. Studying samples of DNA in the laboratory from women who are BRCA1/BRCA2 mutation carriers may help doctors identify biomarkers related to cancer.

NCT ID: NCT00898612 Withdrawn - Lymphoma Clinical Trials

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Start date: March 2008
Phase: N/A
Study type: Observational

RATIONALE: Studying samples of blood in the laboratory from patients who have undergone a donor bone marrow transplant may help doctors learn more about changes that occur in DNA and identify biomarkers related to graft-versus-host disease. It may also help doctors predict how patients will respond to a donor bone marrow transplant. PURPOSE: This laboratory study is looking at early detection of graft-versus-host disease in patients undergoing a donor bone marrow transplant.

NCT ID: NCT00898573 Withdrawn - Breast Cancer Clinical Trials

Lapatinib Resistance in Patients With Breast Cancer

Start date: July 2008
Phase: Phase 1
Study type: Observational

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about cancer and the development of drug resistance in patients. PURPOSE: This research study is looking at lapatinib resistance in patients with breast cancer.